PTEN and glioblastoma: In a recent study, glioblastoma patients who were not responsive to anti-PD-1 immunotherapy were significantly enriched for PTEN mutations and these PTEN mutations may induce a distinct immunosuppressive microenvironment, suggesting PTEN mutations’ involvement in immune reaction regualtion [54].